Cargando…
Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine
Efficacious vaccines are needed to control genital chlamydial diseases in humans and the veterinary industry. We previously reported a C. abortus (Cab) vaccine comprising recombinant Vibrio cholerae ghosts (rVCG) expressing the conserved and immunogenic N-terminal region of the Cab polymorphic membr...
Autores principales: | Richardson, Shakyra, Medhavi, Fnu, Tanner, Tayhlor, Lundy, Stephanie, Omosun, Yusuf, Igietseme, Joseph U., Carroll, Darin, Eko, Francis O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264281/ https://www.ncbi.nlm.nih.gov/pubmed/34249004 http://dx.doi.org/10.3389/fimmu.2021.698737 |
Ejemplares similares
-
A novel cold-chain free VCG-based subunit vaccine protects against Chlamydia abortus-induced neonatal mortality in a pregnant mouse model
por: Richardson, Shakyra, et al.
Publicado: (2023) -
Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection
por: Howard, Simone, et al.
Publicado: (2021) -
MiR-378b Modulates Chlamydia-Induced Upper Genital Tract Pathology
por: Lundy, Stephanie R., et al.
Publicado: (2021) -
Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses
por: Pais, Roshan, et al.
Publicado: (2019) -
Genital tract microbiome dynamics are associated with time of Chlamydia infection in mice
por: Zhao, Lihong, et al.
Publicado: (2023)